0001603018-14-000001.txt : 20140328 0001603018-14-000001.hdr.sgml : 20140328 20140328164339 ACCESSION NUMBER: 0001603018-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140328 DATE AS OF CHANGE: 20140328 EFFECTIVENESS DATE: 20140328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Atlas US Royalty LLC CENTRAL INDEX KEY: 0001603018 IRS NUMBER: 465080826 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-214508 FILM NUMBER: 14726358 BUSINESS ADDRESS: STREET 1: 2091 STIERLIN COURT CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-944-7000 MAIL ADDRESS: STREET 1: 2091 STIERLIN COURT CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 D 1 primary_doc.xml X0707 D LIVE 0001603018 Atlas US Royalty LLC 2091 STIERLIN COURT MOUNTAIN VIEW CA CALIFORNIA 94043 650-944-7000 DELAWARE None None Limited Liability Company true 2013 N/A Alexza Pharmaceuticals, Inc. 2091 Stierlin Court Mountain View CA CALIFORNIA 94043 Promoter The Manager and Class A Member of the Issuer Orlando C. Figueroa Lord Securities Corporation 48 Wall Street, Fl 27 New York NY NEW YORK 10005 Promoter The Class B Member of the Issuer Pharmaceuticals Decline to Disclose 06b false 2014-03-18 false true false 250000 Morgan Stanley & Co. LLC 8209 Morgan Stanley & Co. LLC 8209 1585 Broadway New York NY NEW YORK 10036-8293 MA MASSACHUSETTS NJ NEW JERSEY NM NEW MEXICO NY NEW YORK false 45000000 45000000 0 false 9 3000000 true 0 0 false Atlas US Royalty LLC /s/ Mark K. Oki Mark K. Oki CFO, Alexza Pharmaceuticals, Inc., its Manager 2014-03-28